Targeted Therapy

Related by string. * Targeting . targets . Targets . targeted . targeting . TARGET : target = blank . Target Field . Target Chip Ganassi . roadside bomb targeting . Targeted Genetics . Molecular Targets / THERAPY . therapy : stem cell therapy . Hormone Replacement Therapy . cognitive behavioral therapy . active antiretroviral therapy . gene therapy * molecularly targeted therapy *

Related by context. All words. (Click for frequent words.) 73 Tyrosine Kinase Inhibitor 73 Anti Tumor 73 Clinical Outcome 73 Antigen Specific 72 Epidermal Growth Factor Receptor 72 Circulating Tumor Cells 72 Mouse Model 72 Neoadjuvant Chemotherapy 72 Advanced Melanoma 72 Analytical Tool 72 Kinase Inhibitor 72 Inhibits 72 Adjuvant Therapy 72 Myelodysplastic Syndromes 72 Kinase Inhibitors 72 Improves Survival 72 Shows Promise Against 71 Prolongs Survival 71 Diffuse Large B 71 Aurora Kinase 71 Immunomodulatory 71 Investigational Agent 71 Adjuvant Chemotherapy 71 Solid Tumors 71 Soft Tissue Sarcoma 71 Estrogen Receptor 71 Autologous Stem Cell Transplantation 71 Chemotherapeutic Agents 71 Novel Therapies 71 Mimetics 71 Antitumor Activity 71 Small Molecule 71 Autoimmune Disease 71 Improve Survival 70 Cancer Stem Cells 70 Systemic Delivery 70 Breast Tumors 70 Breast Cancer Recurrence 70 Novel Therapeutic 70 Relapsed Refractory 70 Dendritic Cells 70 Progenitor Cells 70 Present Preclinical Data 70 Signaling Pathways 70 Renal Cell Carcinoma 70 Gene Mutation 70 Anti Tumor Activity 70 Novel Oral 70 Improves Outcomes 70 Appears Safe 70 Dose Response 70 Study Evaluating 70 Meta Analysis 70 Recurrent Breast Cancer 70 Oral Fingolimod 70 Novel Treatments 70 Therapeutic Targets 70 Orally Active 70 Hormone Refractory Prostate Cancer 70 Metastatic Renal Cell Carcinoma 69 Neuroprotection 69 Protein Expression 69 Brain Metastases 69 Mutational 69 Immune Cell 69 Pooled Analysis 69 Diabetic Nephropathy 69 Bone Metastases 69 Tumor Growth 69 Anthracycline 69 Sustained Efficacy 69 Drug Shows Promise 69 Tumor Cells 69 Prognostic Value 69 Statistically Significant 69 Adenoma 69 Dose Escalation 69 Gastric Cancer 69 Treatment Reduces 69 Invasive Breast Cancer 69 Shows Promising 69 Phase 2b Clinical Trial 69 Breast Cancer Cells 69 Phase 2b Study 69 Shown Effective 69 Patients Undergoing 69 Preclinical Study 69 Cancer Cells 69 Clinical Trial Results 69 Inflammatory Markers 69 Intravascular 69 Cardiotoxicity 69 Neuroendocrine Tumors 69 Drug Candidate 69 Pharmacokinetic Study 69 Prospective Randomized 69 Meets Primary Endpoint 69 Inhaled Corticosteroids 69 Hematological Malignancies 69 Minimally Invasive Treatment 69 Less Invasive 69 RNAi Therapeutic 69 Leukemias 69 Proves Effective 69 Prognostic Factors 69 Investigational Treatment 69 Sipuleucel T 69 Risk Stratification 69 Treating Chronic 69 Oral Cavity 69 Hypercholesterolemia 69 Breast Cancer Metastasis 68 Shows Efficacy 68 Anticancer Drug 68 Nicotine Vaccine 68 Tumor Targeting 68 Replacement Therapy 68 Well Tolerated 68 Genetic Variation 68 Genes Involved 68 Monoclonal Antibody 68 Patients Receiving 68 Pivotal Study 68 Skeletal Muscle 68 Antiangiogenic 68 Genetic Marker 68 Protein Linked 68 Previously Treated 68 Immune Responses 68 Epithelial 68 Therapeutic Antibody 68 Genes Predict 68 Inflammatory Arthritis 68 Rheumatoid Arthritis Patients 68 Lung Cancer Drug 68 Hsp# Inhibitor 68 Therapeutic Potential 68 HER2 Positive 68 Preclinical Data 68 Cancer Vaccines 68 Synthetic Peptide 68 Previously Untreated 68 Long Term Efficacy 68 DNA Methylation 68 TNF Alpha 68 Severe Sepsis 68 Factor Receptor 68 Advanced Colorectal Cancer 68 Combination Treatment 68 Genetic Markers 68 Preclinical Models 68 Advanced Renal Cell 68 Multiple Myeloma Patients 68 Oral Mucositis 68 Aptamer 68 Fungal Infections 68 Apoptotic 68 Receives Orphan Drug Designation 68 Combination Therapy 68 Novel Inhibitor 68 Unresectable 68 Mouse Models 68 Proteasome 68 Tumor Cell 68 Renal Function 68 Anti Angiogenesis 68 Allogeneic 68 Chronic Hepatitis C 68 Protease Inhibitor 68 Contrast Agents 68 Renal Artery 68 Antiviral Activity 68 Files IND 68 Lung Cancer Patients 68 Lung Cancers 68 RNAi Therapeutics 68 Randomized Trials 68 Diagnostic Tests 68 Anti Angiogenic 68 Phase IIb Clinical Trial 68 Etiology 67 Bosutinib 67 Test Detects 67 Hepatocellular Carcinoma 67 Anthrax Toxin 67 Potent Anti 67 Radiofrequency Ablation 67 Chronic Lymphocytic Leukemia CLL 67 Clinical Trial Data 67 Refractory Hodgkin Lymphoma 67 Adjuvant Treatment 67 Kidney Function 67 Immunotherapeutic 67 Smooth Muscle 67 Initiate Clinical Trial 67 Sentinel Lymph Node 67 Epratuzumab 67 Treatment Regimen 67 Effective Treatments 67 Combo Therapy 67 Disease Progression 67 Cytotoxicity 67 Signaling Pathway 67 Pertuzumab 67 Complicated Skin 67 Genes Linked 67 Therapeutic Efficacy 67 Carotid Stenting 67 Neural Stem Cells 67 Hormone Receptor Positive 67 Genotypes 67 Pharmacokinetics PK 67 Cancer Biomarkers 67 Antiplatelet Therapy 67 Controlled Study 67 Localized Prostate Cancer 67 Metastatic Colorectal Cancer 67 Deforolimus 67 Randomized Clinical Trials 67 Therapeutic Vaccines 67 Ischemic Stroke 67 Liver Metastases 67 Predict Response 67 Interferon Beta 67 Presents Preclinical Data 67 Molecular Basis 67 Metabolic Disorder 67 Contrast Agent 67 HDAC Inhibitor 67 Tyrosine Kinase Inhibitors 67 Hematological Cancers 67 Breast Density 67 Septic Shock 67 Protease Inhibitors 67 JAK Inhibitor 67 Epithelial Cell 67 Patients Treated With 67 Investigational Compound 67 Antitumor 67 Placebo Controlled Trial 67 Treatment Naive Patients 67 Tumor Suppressor 67 Osteoporosis Treatment 67 Breast Cancer Treatment 67 Left Ventricular 67 Brain Tumors 67 Genes Associated 67 See CLINICAL PHARMACOLOGY 67 Inflammatory Diseases 67 Acute Heart Failure 67 Pralatrexate 67 Transcriptional 67 Differential Diagnosis 67 BiTE Antibody 67 Endothelial 67 Solid Tumor 67 Parathyroid Hormone 67 Prostate Cancer Progression 67 Tyrosine Kinase 67 Stem Cell Transplants 67 Pharmacodynamics 67 Initiates Clinical Trial 67 Cell Transplants 67 Venous Thromboembolism 67 Polymerase Inhibitor 67 Diabetic Foot Ulcer 67 Lung Cancer Survival 67 Hematopoietic Stem Cells 67 Biomarker Study 67 Myeloma Patients 67 CYT# potent vascular disrupting 67 Knee Osteoarthritis 67 Controlled Trial 66 Slow Progression 66 Hedgehog Pathway 66 Gene Linked 66 Breast Cancers 66 Bladder Cancer 66 Magnetic Nanoparticles 66 Newly Diagnosed Multiple Myeloma 66 Chronic Lymphocytic Leukemia 66 Beneficial Effects 66 FDA Okays 66 Squamous Cell Carcinoma 66 Chemoradiation 66 Diabetic Neuropathy 66 Protein Biomarker 66 Tumor Response 66 Chemoprevention 66 Refractory Angina 66 Chemotherapy Improves 66 Demonstrates Potential 66 Nanoemulsion 66 Personalized Immunotherapy 66 Renal Tumors 66 Cell Differentiation 66 Demonstrates Significant 66 HER2 Positive Breast Cancer 66 Ischemic 66 Subtypes 66 Assay Kits 66 Modulates 66 Schizophrenia Treatment 66 Randomized Study 66 Coronary Arteries 66 Inflammatory Disease 66 Balloon Angioplasty 66 Prognostic Significance 66 Metastatic Melanoma 66 Node Positive 66 Transdermal Delivery 66 Neovascularization 66 Protein Synthesis 66 Cytotoxic 66 Demonstrates Positive 66 Autoimmune Disorders 66 Drug Combo 66 Randomized Phase II 66 Anticancer Drugs 66 Drug Resistant 66 Radiation Induced 66 Autoimmune Diseases 66 Subgroup Analysis 66 Demonstrates Efficacy 66 Acute Ischemic Stroke 66 Gene Silencing 66 Hepatitis C Genotype 66 Aflibercept 66 Nuclear Receptors 66 Insulin Resistance 66 Induction Therapy 66 Transcription Factor 66 Investigational Drug 66 Follicular Lymphoma 66 Protein Interactions 66 Anti Inflammatory Drug 66 Myocardial Perfusion Imaging 66 Immune Cells 66 Allosteric 66 Completes Patient Enrollment 66 JAK2 Inhibitor 66 Survival Benefit 66 Metabolic Disease 66 Secondary Hyperparathyroidism 66 Idiopathic Pulmonary Fibrosis 66 Preclinical Efficacy 66 Ovarian Cancer Patients 66 Platelet Inhibition 66 Chronic Inflammation 66 Clinical Efficacy 66 HER1 66 Osteoarthritis Patients 66 Vaccine Adjuvants 66 Initiates Clinical 66 Hematopoietic 66 Respiratory Virus 66 Improved Survival 66 Oxidative Stress 66 Randomized Clinical Trial 66 Treated Patients 66 Fulvestrant 66 Potent Inhibitor 66 Lung Tumors 66 Postmenopausal Women 66 Heart Failure Patients 66 Antigens 66 Develop Novel 66 Randomized Double blind 66 Clinical Evaluation 66 Cerebrospinal Fluid 66 Molecular Mechanism 66 Novel Method 66 Detect Cancer 66 Protein Interaction 66 Improve Outcomes 66 Demonstrated Significant 66 Cutaneous T 66 Decitabine 66 Targeted Therapies 66 Radical Prostatectomy 66 Cyclooxygenase 2 66 Recombinant Human 66 Invasive Fungal Infections 66 Hepatocellular 66 Treatment Naïve 66 Statin Therapy 66 Malignant Melanoma 66 Cardiovascular Outcomes 66 siRNA Delivery 66 Chronic Myelogenous Leukemia 66 Muscle Wasting 66 Metastases 66 Glucocorticoid 66 Hypertensive Patients 66 Treatment Shows Promise 66 Virus Linked 66 Ultrasensitive 66 Phase III Trial 66 gefitinib Iressa 66 Prevent Stroke 66 Novel Approaches 66 Fibroblast 66 Renal Cancer 66 Blood Vessels 66 Dendritic Cell 66 Demonstrates Potent 65 Elderly Patients 65 Novel Protein 65 Epitopes 65 II Clinical Trial 65 Gene Variants 65 Clinical Relevance 65 Genetic Predisposition 65 Cell Adhesion 65 Vertebral Fractures 65 Protein Kinase 65 Node Negative 65 Proven Effective 65 Antifungals 65 Phase IIb Trial 65 Prostate Cancer Treatment 65 Trial Evaluating 65 Gene Variant 65 Universal Flu Vaccine 65 Relapsing Multiple Sclerosis 65 Enlarged Prostate 65 Catheter Ablation 65 Attenuates 65 Innate Immune 65 Novel Mechanism 65 Angiogenic 65 Novel Compound 65 Protein Involved 65 Viral Load 65 Severe Asthma 65 Malignancies 65 Mucosal 65 Cognitive Impairment 65 Molecular Diagnostic 65 Chronic Myeloid Leukemia 65 Endovascular Treatment 65 Chronic Sinusitis 65 Induces 65 Immune Mediated 65 Unfractionated Heparin 65 Atopic Dermatitis 65 Cell Lymphoma 65 Double Blind Placebo 65 Low Dose 65 Diabetic Patients 65 Organ Rejection 65 Pre Cancerous 65 Gene Mutations 65 Resistant Hypertension 65 Adjunctive Therapy 65 Successfully Completes Phase 65 Glioma 65 Tumor Angiogenesis 65 Therapy Shows Promise 65 Malignant Glioma 65 Thyroid Hormone 65 Molecular Mechanisms 65 Transdermal Patch 65 Urinary Incontinence 65 Rotavirus Vaccine 65 Fondaparinux 65 Prophylactic Treatment 65 Myocardial Ischemia 65 Phase 2a Trial 65 Renal Cell Cancer 65 Blood Pressure Drug 65 Randomized Double Blind 65 Myocardial Perfusion 65 Relapsed Refractory Aggressive 65 Immunogenicity 65 Anticancer Agent 65 Cancer Therapies 65 Romidepsin 65 Oligonucleotides 65 Long Term Survival 65 Prostate Cancer Patients 65 Vitro Activity 65 Sirolimus Eluting Stent 65 Companion Diagnostic 65 Hospital Acquired Pneumonia 65 Fewer Side Effects 65 Bucindolol 65 Prolongs Life 65 Neoplasms 65 Cell Proliferation 65 Squamous 65 Preclinical Evaluation 65 Genetic Mutation 65 Cardiovascular Events 65 Anticancer Activity 65 Breast Tumor 65 Lymphoid 65 Blood Pressure Lowering 65 Skin Lesions 65 Overactive Bladder 65 Patient Outcomes 65 Extracellular Matrix 65 Dengue Virus 65 Predict Prostate Cancer 65 platform HDL Mimetic 65 Leukemia Cells 65 Effectively Treats 65 Castration Resistant Prostate Cancer 65 Experimental Vaccine 65 Sapacitabine 65 Drug Prevents 65 Hepatitis C Infection 65 Cancer Treatments 65 Cytochrome P# 65 Breast Cancer Patients 65 Oral Calcitonin 65 Infected Patients 65 Asthma Treatment 65 Colorectal Cancer Patients 65 Cyclophosphamide 65 Biomarker 65 Therapy Evaluation 65 Study Demonstrates 65 IND Application 65 Monotherapy 65 Cardiovascular Disease Risk 65 Combination REOLYSIN R 65 Fludarabine 65 Patient Enrollment 65 Hepatitis C Virus 65 Transplant Rejection 65 Pulmonary Arterial Hypertension 65 Prostate Cancers 65 Gastrointestinal Stromal Tumors 65 Myelodysplastic Syndrome 65 Lowers Risk 65 Lymphocytic 65 Antifungal 65 Pediatric Patients 65 Aggressive Prostate Cancer 65 Sleep Disturbances 65 Initiates Enrollment 65 Genetic Disorder 65 Dose Ranging Study 65 Gene Variation 65 Surgical Treatment 65 Non Invasive Treatment 65 Phase 2b Trial 65 Antiplatelet 65 ORLive Presents 65 Randomized Phase 65 Receptor Agonist 65 Non Invasive 65 Omacetaxine 65 Gene Expression Profiling 65 Vaccine Shows Promise 65 Bevacizumab 65 Chronic Heart Failure 65 Embolization 65 Nilotinib 65 Cholesterol Lowering Drug 65 Cervical Dysplasia 65 Phase III Clinical Trial 65 FDA Approvals 65 Therapy Improves 64 Significantly Improved 64 Predict Breast Cancer 64 fosbretabulin 64 Multicenter Phase 64 Peripheral Blood 64 Inflammatory Pain 64 Ofatumumab 64 Clostridium difficile Infection 64 Antisense Drug 64 Naive Patients 64 Lentiviral 64 Liver Tumors 64 Colon Polyps 64 Chronic HCV 64 Vaccine Adjuvant 64 Blinatumomab 64 Biologic Therapy 64 Atypical Hemolytic Uremic Syndrome 64 Spinal Fluid 64 Shows Promise 64 Metastatic Prostate Cancer 64 Hemodialysis Patients 64 Reperfusion Injury 64 Blocked Arteries 64 Patients Suffering 64 Insulin Sensitivity 64 Small Intestine 64 Phase IIa Clinical Trial 64 Unstable Angina 64 Spinal Fusion 64 Companion Diagnostics 64 Lupus Nephritis 64 Radioimmunotherapy 64 Alvine Pharmaceuticals 64 Dual Antiplatelet Therapy 64 Treating Heart Failure 64 Metabolites 64 Endothelial Cells 64 NASH Huntington 64 Phenotypes 64 Therapeutic Antibodies 64 Enzastaurin 64 Prostate Cancer Recurrence 64 Critically Ill Patients 64 RNA Interference 64 Mantle Cell Lymphoma 64 Intracranial Aneurysms 64 Fixed Dose 64 Cellular Immunotherapy 64 Liposomal 64 Pluripotent Stem Cells 64 B Cell Lymphoma 64 Virus Infection 64 Hepatic Encephalopathy 64 Newly Diagnosed 64 Molecular Diagnostic Test 64 Initiate Phase 64 Cervical Spine 64 Rheumatoid Arthritis Drug 64 Lupus Drug 64 Hormonal Therapy 64 Brain Aneurysms 64 Percutaneous Tibial Nerve Stimulation 64 Treat Heart Failure 64 Epilepsy Drug 64 Antiviral Drugs 64 Potent Antiviral Activity 64 Scientists Identify 64 Macrophage 64 TNF Blockers 64 Sustained Release 64 Polymorphisms 64 Advanced Prostate Cancer 64 Fibrosis 64 Anti CD# Antibody 64 Intravesical 64 Maven Semantic 64 Novel Vaccine 64 Tumor Markers 64 Eculizumab 64 metastatic malignant 64 Homeostasis 64 Benign Prostatic Hyperplasia 64 Fluorouracil 64 Medullary Thyroid Cancer 64 Advanced Ovarian Cancer 64 Confirmatory Phase 64 Teva Provides Update 64 Osteoporosis Drug 64 Breast Tissue 64 Glufosfamide 64 Lung Injury 64 Immune Function 64 Peginterferon 64 Beta Blocker 64 Clinical Trial Evaluating 64 Image Guided 64 Obese Patients 64 Cocaine Addiction 64 mTOR mammalian target 64 Genes Identified 64 Increased Mortality 64 Reduced Risk 64 Tumor Necrosis Factor 64 Observational Study 64 Crit Rev 64 Prostate Biopsy 64 Multiple Myeloma MM 64 Tumor Suppressor Gene 64 Multicenter Randomized 64 Antiviral Therapy 64 Bone Marrow Cells 64 Randomized Controlled Trial 64 Oral Formulation 64 Neuroprotective Effects 64 Intracerebral Hemorrhage 64 First Patient Treated 64 Prolonged Survival 64 Histone Deacetylase 64 Myeloid 64 Kidney Transplant Patients 64 Vidaza ® 64 Potentially Fatal 64 Novel Antibiotic 64 Synthase 64 Collaborators Present 64 Artificial Pancreas 64 thalidomide Thalomid 64 JAK2 V#F 64 Novel Compounds 64 Phase III Trials 64 Tiotropium 64 Ozarelix 64 Antipsychotic Drug 64 Treating Depression 64 Helps Predict 64 5 Fluorouracil 64 Inactivation 64 Fibrinogen 64 Xelox 64 Slows Progression 64 Intra Arterial 64 Left Ventricular Hypertrophy 64 Proteases 64 Efficacious 64 Enzyme Replacement Therapy 64 Estrogen Therapy 64 Neoadjuvant 64 Endometrial Cancer 64 TNF Tumor Necrosis Factor 64 Carcinomas 64 Aneurysm Repair 64 CT Angiography 64 Cancer Recurrence 64 Asthma COPD 64 Single Molecule 64 Platinol ® 64 Study Showed 64 Peginterferon Alfa 2a 64 Aggressive Reduction 64 Diastolic Heart Failure 64 Hepatitis C Treatment 64 Onyx Pharmaceuticals Announces 64 Bone Marrow Stem Cells 64 Leukocyte 64 Secretion 64 Hyperlipidemia 64 myelofibrosis polycythemia vera 64 Is Well Tolerated 64 Myelofibrosis 64 Single Dose 64 Coronary Angiography 64 Viral Suppression 64 Nymox NX 64 Initiates Phase III 64 FDA Accepts 64 Blood Flow 64 Taxane 64 Genetic Tests 64 Disease Modifying 64 Nucleoside 64 Regimens 64 Therapeutic Vaccine 64 Tolerability 64 Progenitor Cell 64 Novel Approach 64 Humanized Anti 64 Lung Cancer Trial 64 Reduces Mortality 64 Menstrual Pain 64 Pancreatic Adenocarcinoma 64 Oncolytic Reovirus 64 Androgen Receptor 64 Interferon Gamma 64 Systematic Review 64 Physician Insights 64 Chemotherapy Induced 64 Ovarian Cancers 64 Oncogenic 64 Combination Clinical Trial 63 Etanercept 63 Help Predict 63 Blood Cancers 63 Small Molecules 63 HCV Protease Inhibitor 63 Mesothelioma Treatment 63 Genetic Basis 63 Boosts Survival 63 Monoclonal 63 Pegylated Interferon 63 Sangamo BioSciences Announces 63 Angiographic 63 Key Attributes 63 Vaccine Protects Against 63 Aortic Stenosis 63 Receptor Antagonists 63 Emerging Therapies 63 Minimally Invasive Procedure 63 Contrast Enhanced 63 Chronic Rhinosinusitis 63 Laryngeal Cancer 63 Metastatic Disease 63 Researchers Identify 63 Commercialize Novel 63 Recombinant Protein 63 Interferon Alfa 63 Valve Replacement 63 Placebo Controlled 63 Brain Scans 63 Follicular 63 Pegylated 63 Sentinel Lymph Node Biopsy 63 Treatment Resistant 63 Autologous 63 Protein Kinase Inhibitors 63 Paroxysmal Nocturnal Hemoglobinuria PNH 63 First Patient Enrolled 63 Placebo Controlled Study 63 Randomized Controlled Trials 63 Medoxomil 63 Diagnostic Criteria 63 Carotid Endarterectomy 63 Erectile Dysfunction Drug 63 Glycemic Control 63 Protein Kinase C 63 Osteopontin 63 Eluting Stent 63 Optical Coherence Tomography 63 Postdoctoral Position 63 Monoclonal Antibodies 63 Chronic Pelvic Pain 63 Juvenile Idiopathic Arthritis 63 Multicenter Study 63 Androgen Deprivation Therapy 63 Cognitive Deficits 63 Immunostimulatory 63 Cardiac Function 63 Randomized Phase III 63 Novel Small Molecule 63 Relapsing Remitting Multiple Sclerosis 63 Immunotherapies 63 bevacizumab Avastin ® 63 Aliskiren 63 Stem Cell Treatment 63 Chronic Renal Failure 63 Genetic Variant 63 Protease 63 Myelodysplastic Syndrome MDS 63 Dehydrogenase 63 Stakeholder Opinions 63 Intracellular 63 Drug Eluting 63 Imaging Technique 63 PKC# 63 Adjuvant Breast Cancer 63 Total Knee Arthroplasty 63 Hernia Repair 63 Mechanistic 63 Cytotoxic T 63 Implantable Device 63 Phospholipase A2 63 Stomach Cancer 63 Nerve Cells 63 Gender Differences 63 Lymph Nodes 63 Immunomedics Announces 63 Early Diagnosis 63 Patients Treated 63 Reduces Pain 63 Prostate Tumors 63 Watchful Waiting 63 Catheter Associated 63 Technological Advances 63 Expanded Indication 63 Remission Maintenance 63 Iron Deficiency 63 Hematologic 63 First Patient Dosed 63 downstream effector 63 Pegylated Liposomal Doxorubicin 63 Lowering Blood Pressure 63 NDA Submission 63 Cytarabine 63 Clinical Validation 63 Ranolazine 63 Therapy Reduces 63 Nicotinic 63 Vaccine Candidate 63 Nerve Cell 63 Gout Drug 63 Skin Cells 63 Phase Ib Clinical Trial 63 metastatic neuroendocrine tumors 63 AnaSpec Introduces 63 Mutagenesis 63 Randomized Controlled 63 Tumor Microenvironment 63 Arthritis Drug 63 Drug Fails 63 Azacitidine 63 Novel Peptide 63 CYP#A# CYP#D# 63 Treatment Experienced 63 Phase 1b Clinical Trial 63 Ligands 63 Tigecycline 63 Treatment Naïve Patients 63 Long Term Outcomes 63 Levels Linked 63 Pathway Inhibitor 63 Talabostat 63 Venous Thrombosis 63 Conjugated 63 Human Neural Stem 63 Carboplatin Paclitaxel 63 Breast Cancer Stem Cells 63 Anticoagulant 63 FDA Approves Drug 63 Acute Myocardial Infarction 63 Adenoviral 63 Denufosol 63 Granted Orphan Drug 63 Predict Risk 63 Stent Placement 63 Retinal Vein Occlusion 63 Polymorphism 63 Histone 63 Protein Biomarkers 63 Breast Ultrasound 63 Angiogenesis 63 Premenopausal Women 63 Naturally Occurring 63 transcranial Doppler ultrasound 63 Lung Cancer Treatment 63 Prospective Multicenter 63 Prostate Cancer Risk 63 Therapeutic Agents 63 Oligonucleotide 63 Confirms Efficacy 63 Could Predict 63 X Chromosome 63 Insulin Glargine 63 Salivary 63 Trodusquemine MSI 63 Receptor Antagonist 63 Newly Diagnosed Breast Cancer 63 Multicenter 63 Treatment Naive HIV 63 Susceptibility Gene 63 Platelet Derived Growth 63 Induction Chemotherapy 63 Migraine Headache 63 Relapsed 63 Acute Coronary Syndromes 63 Confocal Microscopy 63 Corgentin 63 Impairs 63 Pivotal Phase 63 Viral Infections 63 Antibody Drug Conjugate 63 Transfection 63 refractory chronic lymphocytic 63 Antiarrhythmic 63 Enzyme Linked 63 Fast Skeletal Troponin 63 Advanced Solid Tumors 63 Progressive Multifocal Leukoencephalopathy 63 Pivotal Trial 63 Initiates Phase II 63 Hormone Therapy 63 Epitope 63 Thalamus 63 J Clin 63 Safinamide 63 Plus Ribavirin 63 Thrombotic 63 Efficacy Trial 63 topoisomerase II inhibitor 63 Pathogen Detection 63 Hospitalized Patients 63 Immunosuppression 63 Receives Orphan Drug 63 Carcinoid 63 sunitinib Sutent 63 Tezampanel 63 Dyslipidemia 63 Xenografts 63 REMINDER ORLive Presents 63 Kidney Transplants 63 Oncolytic 63 Ischaemic 63 Vidaza azacitidine 63 Protein Protein Interactions 63 Anti Inflammatory Drugs 63 Therapeutic Effects 63 Highly Accurate 63 Commonly Used 63 Depressive Symptoms 63 Thromboembolism 63 EGFR HER2 63 Phosphatase 63 Cannabinoid 63 Heart Transplant Recipients 63 registrational Phase 63 Prove Effective 62 Achieves Primary Endpoint 62 Cognitive Function 62 Pharmacodynamic 62 Diagnostic Tools 62 targeted radiotherapeutic 62 Left Ventricular Dysfunction 62 Pharmacogenomic 62 Anti Inflammatory 62 Antidepressants Linked

Back to home page